Scotland launched the latest version of its strategy to become one of world’s top locations for life sciences by 2020, as the hopes vested in two of its leading research companies Stem Cell Sciences and Ardana Biosciences, turned to dust.
Thin drug pipelines prompted the biopharmaceuticals licensing splurge of 2006/7. Now pharma and large biotechs are looking to tap into university research too.
It’s tough starting a technology business anywhere – but that’s especially true in Central and Eastern Europe…and Trainingpoint’s Ivo Smelhaus talks from bitter experience.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.